All In Biotech

Drug Trial Radar · NCT05546398

SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI®

SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI® (Fixed Dose Combination of Bempedoic Acid 180mg and Ezetimibe 10mg) as add-on to Treatment With Maximally Tolerated Statin Therapy in Routine Clinical Practice

Last checked: Nov 19, 2026Latest source record: Dec 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

500

Actual

Start

Apr 22, 2022

Primary completion

Nov 17, 2022

Study completion Nov 17, 2022

Sponsor

Sponsor type
Industry
Collaborators
Daiichi Sankyo Germany
First posted
Sep 19, 2022

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this study, a survey of office-based cardiologists and lipid management specialists will be conducted on treatment decisions for NUSTENDI® (bempedoic acid 180 mg fixed dose combination \[FDC\] with ezetimibe 10 mg) followed by a retrospective chart review of patients at high and very-high cardiovascular risk with hypercholesterolemia or mixed dyslipidemia who were treated with FDC as add-on to treatment with maximally tolerated statin therapy in routine clinical practice.

Conditions

  • Hypercholesterolemia
  • Mixed Dyslipidemia

Interventions

  • Bempedoic Acid 180Mg/Ezetimibe 10Mg TabDrug

    No study drug was administered during this study.

  • No study drugOther

    No study drug was administered during this study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Low density Lipoprotein-Cholesterol (LDL-C) Levels at Therapy Decision Based on Physician SurveyTime frame: Up to 6 months
  2. Reductions in Low density Lipoprotein-Cholesterol (LDL-C) Levels Based on Physician SurveyTime frame: Up to 6 months
  3. Visual Analogue Scale (VAS) Score Evaluating Relevance of Decision Factors and Considerations Relevant to Therapy Decision Based on Physician SurveyTime frame: Up to 6 months
  4. Low density Lipoprotein-Cholesterol (LDL-C) Levels at Therapy Decision Based on a Retrospective Patient Chart ReviewTime frame: Up to 6 months
  5. Number of Participants With Pre-specified Events in Their Medical History Based on a Retrospective Patient Chart ReviewTime frame: Up to 6 months
  6. Number of Participants With Specific Concomitant Diseases Based on a Retrospective Chart ReviewTime frame: Up to 6 months
  7. Number of Participants Implementing Specific Lifestyle Modifications Based on a Retrospective Patient Chart ReviewTime frame: Up to 6 months

Locations

63 sites in 1 country. Site status is shown where the registry gives one.

  • Kardiologische Gemeinschaftspraxis (Bulut)

    Arnsberg, Germany

  • Dr. Georg Strack

    Bad König, Germany

  • Dr. J. Nothroff

    Berlin, Germany

  • Kardiologie am Spreebogen (Krackhardt)

    Berlin, Germany

  • Kardiologie Spreebogen Berlin (Haverkamp)

    Berlin, Germany

  • Kardiologische Facharztpraxis Winkelmann

    Berlin, Germany

  • SPK-Studienzentrum Rankestraße GmbH

    Berlin, Germany

  • Kardio Bonn

    Bonn, Germany

  • Dr. Jaroslaw Sek

    Chemnitz, Germany

  • Praxis Dipl.-med. Schermaul

    Chemnitz, Germany

  • Praxis für Kardiologie und Schlafmedizin (Lichtenberg)

    Cologne, Germany

  • BAG Helmecke

    Crivitz, Germany

  • Kardiologie Darmstadt

    Darmstadt, Germany

  • MVZ Rhein-Main GmbH (Binder)

    Dreieich, Germany

  • Cardiologicum Dresden / Pirna (Hildebrandt)

    Dresden, Germany

  • Facharztzentrum Dresden-Neustadt GbR (Simonis)

    Dresden, Germany

  • PD Dr. Stephan Wiedemann

    Dresden, Germany

  • Praxis Dr. Methfessel

    Dresden, Germany

  • KardioPraxis Rote Straße (Stieber)

    Duisburg, Germany

  • Kardiologische Praxis (Warzok)

    Gotha, Germany

  • Kardiopraxis Greiz (Walter)

    Greiz, Germany

  • MVZ des Krankenhaus Greiz

    Greiz, Germany

  • Kardiologie am Tibarg (Twisselmann)

    Hamburg, Germany

  • Diabetiker Zentrum Hannover (Fendler)

    Hanover, Germany

  • Kardiologie Haßloch (Gerhards)

    Haßloch, Germany

  • Kardiologie Alsterquelle

    Henstedt-Ulzburg, Germany

  • Praxis Dr. Lißmann

    Homburg, Germany

  • Gemeinschaftspraxis Dr. Täschner / Dr. Bonigut

    Leipzig, Germany

  • Praxis Dr. Feige

    Leipzig, Germany

  • Gemeinschaftspraxis Schauermann

    Meiningen, Germany

  • Gemeinschaftspraxis Dres. med. Dittgen/Wilhelm/Rehlinger

    Mettlach, Germany

  • Hausarztpraxis Doreen Drews

    Michendorf, Germany

  • Hausarztpraxis Thorsten Drews

    Michendorf, Germany

  • Kardio Praxis Mülheim (Möllenberg)

    Mülheim, Germany

  • Dres. Bettenworth & Partner

    Münster, Germany

  • Gemeinschaftspraxis am Jahnufer (Schleß)

    Neu-Ulm, Germany

  • Kardiopraxis (Buchholz-Sanchez)

    Neustadt, Germany

  • Kardiologie am Weißen Turm (Stadelmann)

    Nuremberg, Germany

  • Praxis für Kardiologie (Laser)

    Nuremberg, Germany

  • Dres. Kornadt und Edel

    Oberhausen, Germany

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.